Kaiser Family Foundation, CSIS host panel discussion on IOM's PEPFAR evaluation

On Tuesday, April 30, from 2:00-3:30 p.m., the Kaiser Family Foundation and the Center for Strategic and International Studies (CSIS) Global Health Policy Center will host a panel discussion, titled "The Policy Implications of the Institute of Medicine's Evaluation of PEPFAR," at the CSIS conference center in Washington, D.C. Moderated by J. Stephen Morrison, CSIS vice president and director of the CSIS Global Health Policy Center, the panel will include Chris Collins, vice president and director of public policy at amfAR, the Foundation for AIDS Research; Jennifer Kates, vice president and director of global health and HIV policy at the Kaiser Family Foundation; Julia Martin, deputy global AIDS coordinator in the Office of the Global AIDS Coordinator; and Kimberly Scott, senior program officer at the Institute of Medicine. To attend, RSVP at www.smartglobalhealth.org/iomPEPFAR or visit www.smartglobalhealth.org/live to view a live webcast of the event (4/25).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research explores how antimicrobial exposure affects Parkinson’s disease risk